Nu Skin Enterprises, Inc. (NYSE:NUS) Director Andrew D. Lipman Sells 1,000 Shares


Nu Skin Enterprises, Inc. (NYSE:NUS – Get Rating) Director Andrew D. Lipman sold 1,000 shares of the stock in a transaction that occurred on Friday, July 22nd. The shares were sold at an average price of $43.00, for a total value of $43,000.00. Following the transaction, the director now directly owns 71,393 shares of the company’s stock, valued at approximately $3,069,899. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Nu Skin Enterprises Price Performance

NYSE:NUS opened at $42.70 on Friday. Nu Skin Enterprises, Inc. has a one year low of $39.40 and a one year high of $56.76. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.95 and a current ratio of 1.72. The stock has a market cap of $2.14 billion, a PE ratio of 15.81 and a beta of 1.21. The stock has a 50 day moving average price of $44.53 and a 200 day moving average price of $47.15.

Nu Skin Enterprises (NYSE:NUS – Get Rating) last posted its quarterly earnings results on Wednesday, May 4th. The company reported $0.76 EPS for the quarter, beating the consensus estimate of $0.73 by $0.03. The firm had revenue of $604.90 million during the During quarter, compared to analysts’ expectations of $579.70 million. Nu Skin Enterprises had a return on equity of 22.05% and a net margin of 5.28%. The business’s revenue for the quarter was down 10.7% on a year-over-year basis. the same quarter last year, the firm earned $0.91 earnings per share. Equities research analysts expect that Nu Skin Enterprises, Inc. will post 3.64 EPS for the current fiscal year.

Nu Skin Enterprises Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, June 8th. Investors of record on Friday, May 27th were given a $0.385 dividend. The ex-dividend date was Thursday, May 26th. This represents a $1.54 annualized dividend and a yield of 3.61%. Nu Skin Enterprises’s payout ratio is 57.04%.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Covestor Ltd purchased a new position in Nu Skin Enterprises in the fourth quarter worth approximately $48,000. Quadrant Capital Group LLC boosted its position in shares of Nu Skin Enterprises by 47.1% during the fourth quarter. Quadrant Capital Group LLC now owns 1,068 shares of the company’s stock worth $54,000 after buying an additional 342 shares during the period. JJJ Advisors Inc. boosted its position in shares of Nu Skin Enterprises by 216.9% during the fourth quarter. JJJ Advisors Inc. now owns 1,870 shares of the company’s stock worth $95,000 after buying an additional 1,280 shares during the period. Gladius Capital Management LP purchased a new position in shares of Nu Skin Enterprises during the fourth quarter worth $98,000. Finally, Signaturefd LLC boosted its position in shares of Nu Skin Enterprises by 43.5% during the fourth quarter. Signaturefd LLC now owns 2,343 shares of the company’s stock wo rth $119,000 after buying an additional 710 shares during the period. 93.79% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the company. TheStreet raised Nu Skin Enterprises from a “c+” rating to a “b” rating in a report on Tuesday, June 7th. StockNews.com raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Wednesday, June 22nd. Two analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, Nu Skin Enterprises currently has an average rating of “Moderate Buy” and an average price target of $61.50.

Nu Skin Enterprises Company Profile

(Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.

Further Reading

Insider Buying and Selling by Quarter for Nu Skin Enterprises (NYSE:NUS)



Receive News & Ratings for Nu Skin Enterprises Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Nu Skin Enterprises and related companies with MarketBeat.com’s FREE daily email newsletter.

.

Leave a Reply

Your email address will not be published.